Hyperthermia Cancer Treatment Market: Introduction
According to the report, the global hyperthermia cancer treatment market was valued at ~US$ 155 Mn in 2019 and is projected to expand at a CAGR of ~6% from 2020 to 2030. Hyperthermia, (also called thermal therapy or thermotherapy) is a type of cancer treatment, in which body tissue is exposed to high temperatures to damage or kill cancer cells.
The hyperthermia treatment is a non-invasive method of increasing tumor temperature to stimulate blood flow, increase oxygenation, and render tumor cells more sensitive to radiation. By adding hyperthermia to radiation therapy, radiation oncologists can increase tumor control, while minimizing damage to healthy tissues. North America dominated the global hyperthermia cancer treatment market in 2019. The trend is anticipated to continue during the forecast period, owing to increase in incidence of different types of cancer and rise in diagnosis rate in the region.
Request Brochure of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=31334
Increase in Funding for Cancer Research to Drive Hyperthermia Cancer Treatment Market
Funding for cancer research and investment in this area enables expansion of various projects undertaken and personnel employed. Sources of R&D spending include commercial organizations and government funding. Governments in developed countries such as the U.S. raise funds for cancer research to aid in the diagnosis and treatment. Clinical trials are also funded by governments to support companies in developing effective cancer cachexia treatment drugs. This is driving the global hyperthermia cancer treatment market. For instance, in April 2016, the U.S. Government allotted US$ 5.2 Bn to a Federal Government agency, National Cancer Institute (NCI), for cancer research and training.
Microwave Hyperthermia Devices to Dominate Global Market
In terms of device type, the global hyperthermia cancer treatment market has been classified into infrared hyperthermia devices, ultrasound hyperthermia devices, microwave hyperthermia devices, and others. The microwave hyperthermia devices segment is anticipated to grow at a rapid pace during the forecast period, as microwave technique enables heat treatment of tumors, which are deep-seated and/or relatively hard to access in the body. Hence, the preference is high among doctors. This drives the demand for microwave hyperthermia devices in cancer treatment.
Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=31334
Locoregional to be Highly Lucrative Treatment Method
Based on treatment method, the global hyperthermia cancer treatment market has been bifurcated into locoregional and whole-body. The locoregional segment held a major share of the global market in 2019, owing to rise in adoption of locoregional method in the treatment of cancer associated with body cavity, organ, or limb, and increase in incidence of lung and prostate cancers.
Breast Cancer to be Key Application Area
In terms of application, the global hyperthermia cancer treatment market has been divided into breast cancer, liver cancer, soft tissue sarcoma, head & neck tumors, prostate cancer, and others. The increase in incidence of breast cancer is expected to drive the segment during the forecast period. According to the World Health Organization, breast cancer is the most commonly occurring cancer in women and the second most common cancer overall. Over 2 million new cases of breast cancer were diagnosed globally in 2018.
Buy Hyperthermia Cancer Treatment Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=31334<ype=S
North America to Dominate Hyperthermia Cancer Treatment Market
In terms of region, the global hyperthermia cancer treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2019, followed by Europe. North America accounted for a major share of the global hyperthermia cancer treatment market in 2019, attributed to increase in incidence of diseases and new product launches. The rise in incidence of cancers such as breast and liver and a highly structured healthcare industry fuel the growth of the market in Asia Pacific. According to the World Health Organization, 4,285,033 new cancer cases were diagnosed in China in 2018, with 2,865,174 cancer deaths.
Competition Landscape of Hyperthermia Cancer Treatment Market
Key players in the global hyperthermia cancer treatment market include Pyrexar Medical, Celsius42 GmbH, Hydrosun GmbH, Oncotherm Kft, Andromedic S.r.l., Yamamoto Vinita Co., Ltd., Chongqing Haifu Medical Technology Co., Ltd., innoMedicus Ltd., Gamida, and RanD.
More Trending Reports by Transparency Market Research –
Life Sciences BPO Market: https://www.prnewswire.com/news-releases/adoption-of-rpa-technology-to-outsource-manual-repetitive-tasks-to-drive-life-sciences-bpo-market-tmr-insights-301345998.html
Vascular Closure Devices Market: https://www.prnewswire.com/news-releases/vascular-closure-devices-market-to-reach-usd-1-billion-valuation-innovation-crucial-for-growth-tmr-301089917.html
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
